The dual roles of the KEAP1-NRF2 pathway in preventing or initiating pancreatic cancer primarily depend on the stages of cancer and the states of KEAP1 and NRF2 [27]. This evidence concerns the gene NFE2L2 and familial pancreatic carcinoma.